Skip to Main Content

Advisory Panel on Clinical Diagnostic Laboratory Tests

Request for Nominations to the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests
Posted on 12/12/2017; Continuous Solicitation

CMS requests nominations to fill vacancies on the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests. See the Notice for nomination criteria, and send nomination packages to CDLTPanel@cms.hhs.gov. We receive nominations on a continuous basis.

The Advisory Panel on Clinical Diagnostic Laboratory Tests is authorized by section 1834A(f)(1) of the Social Security Act (42 USC 1395m-1).  The Panel is governed by the provisions of section 216 of Public Law 113-93—April 1, 2014, and the Federal Advisory Committee Act (FACA), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory panels.

What is the purpose of the Panel?

The purpose of the Panel is to advise the Secretary of the Department of Health and Human Services (HHS), and the Administrator of the Centers for Medicare & Medicaid Services (CMS), on issues related to clinical diagnostic laboratory test, specifically:

  • the establishment of payment rates under section 1834A of the Social Security Act for new clinical diagnostic laboratory tests, including whether to use crosswalking or gapfilling processes to determine payment for a specific new test; and
  • the factors used in determining coverage and payment processes for new clinical
    diagnostic laboratory tests.

In addition, the Panel may provide recommendations to the Secretary of HHS and the Administrator of CMS under section 1834A of the Act.

Who makes up the Panel?

The panel is composed of individuals with expertise in issues related to clinical diagnostic laboratory tests and may include:

  • representatives of clinical laboratories
  • molecular pathologists
  • clinical laboratory researchers
  • individuals with expertise in clinical laboratory science or health economics.

Panel Charter

The Charter outlines the Panel’s objectives, scope of activities, and description of duties.

View the past charter.

Panel Meetings

The Panel meetings are open to the public except as determined otherwise by the Secretary or other authorized official. We will publish a notice in the Federal Register announcing upcoming Panel meetings.

Panel Recommendations

Subcommittee Reports

Advanced Diagnostic Laboratory Tests Subcommittee

Automated Tests Panel Subcommittee

Note: Visitor Access to Federal Buildings

The Real ID Act, enacted in 2005, establishes minimum standards for the issuance of state-issued driver’s licenses and identification (ID) cards. It prohibits Federal agencies from accepting an official driver’s license or ID card from a state unless the Department of Homeland Security determines that the state is in compliance with the Real ID Act.

Beginning in October of 2015, photo IDs (such as a driver’s license) issued by a state or territory not in compliance with the Real ID Act will not be accepted as identification to enter Federal buildings. As of January 26, 2016, the following states/territories are not compliant with the Real ID Act:  American Samoa, Illinois, Missouri, Minnesota, New Mexico, and Washington. This means CMS visitors from these states/territories will have to be escorted at all times while in CMS buildings. CMS visitors from these states/territories need to provide alternative proof of identification (such as a passport) to gain entrance into Baltimore-based and Bethesda CMS buildings, as well as the Humphrey Building in Washington, DC.  For CMS regional office locations the Real ID Act requirements are implemented by Federal Protective Services.

Please contact CMS Security for specific guidance in regional office locations.

.